Compare Cronos Group Inc (CRON) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs OneSpan Inc — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while OneSpan Inc trades at $15.19 (market cap $574.63M). The key difference: Cronos Group Inc is the larger of the two by market cap, and OneSpan Inc pays a 3.35% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | OSPN | |
|---|---|---|
Market Cap | $1.02B | $574.63M |
Sector | Health | Technology |
52-Week High | $3.27 | $16.32 |
52-Week Low | $1.95 | $10.15 |
Enterprise Value | $203.29M | $532.83M |
Dividend Yield | — | 3.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
OneSpan (OSPN) trades at $15.09, down 0.53% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company demonstrates strong profitability with a net income margin of 28.47% and has beaten earnings estimates for the last three quarters. Recent news highlights investor attention and the upcoming Q2 2026 earnings release on August 4, 2026.
The outlook remains positive given consistent earnings beats and a 66.7% analyst buy rating, though the consensus price target of $13.50 suggests limited upside. Risks include negative net cash flow trends and potential margin compression, but strong ROE of 27.81% supports shareholder value. The stock presents a value opportunity with a P/E of 8.56, but investors should monitor execution against future guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
